Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma

Thymic carcinoma (TC) is a rare cancer with minimal evidence of survival following palliative‐intent chemotherapy. Sunitinib, everolimus, and pembrolizumab have been proposed as active agents based on previous phase II trials. In this phase II study, TC patients previously treated with platinum‐base...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Okuma, Yusuke, Goto, Yasushi, Ohyanagi, Fumiyoshi, Sunami, Kuniko, Nakahara, Yoshiro, Kitazono, Satoru, Kudo, Keita, Tambo, Yuichi, Kanda, Shintaro, Yanagitani, Noriko, Horiike, Atsushi, Horinouchi, Hidehito, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Nishio, Makoto, Ohe, Yuichiro, Hosomi, Yukio
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7571815/
https://ncbi.nlm.nih.gov/pubmed/32813912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3385
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados